5.7K
The FDA LNO, logged as Prenotification Consultation (PNC) No. 3291, authorises Nextloopp rPP for use at levels up to 100% across all food types and under Conditions of Use A through H, spanning the full spectrum of applications – from high-temperature heat sterilisation to frozen storage.
Following a detailed review of Nextloopp’s recycling process and feedstock controls, the FDA concluded that the system is expected to produce rPP of suitable purity, provided the feedstock is sourced from compliant food-contact articles.
Nextloopp continues to make progress with the European Food Safety Authority (EFSA) review, while already being able to place resin on the EU and UK markets prior to the formal EFSA process, which typically takes two years.
